Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Significance of Antibodies to Heparin/Platelet Factor 4 Complex in Vein Graft Patency and Potential Role of Argatroban for Prevention of Vein Graft Occlusion

NCT01246011 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT01246011
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01246011 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Significance of Antibodies to Heparin/Platelet Factor 4 Complex in Vein Graft Patency and Potential Role of Argatroban for Prevention of Vein Graft Occlusion
Lead sponsor
Massachusetts General Hospital
Phase
Phase 4
Overall status
Terminated
Start date
November 30, 2010
Completion date
July 31, 2011
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery bypass graft surgery, presence of heparin/platelet factor 4 antibody